Inspire Medical Systems (INSP) Proxy filing summary

Executive summary

• Annual meeting scheduled for April 30, 2026, with virtual participation available to shareholders.

• Shareholders are encouraged to review proxy materials and vote by April 29, 2026.

Voting matters and shareholder proposals

• Election of three Class II directors: Gary L. Ellis, Georgia Melenikiotou, and Dana G. Mead, Jr.

• Ratification of Ernst & Young LLP as independent auditor for 2026.

• Advisory vote on executive compensation and on the frequency of future say-on-pay votes.

• Amendment to phase out classified board structure, moving to annual director elections starting 2029.

• Amendment and restatement of the 2018 Incentive Award Plan.

• Approval to adjourn the meeting if more time is needed to solicit votes for key proposals.

Board of directors and corporate governance

• Proposal to eliminate the classified board structure, transitioning to annual elections for all directors by 2029.